Month: June 2021

No new license plates being produced in Arizona The White House will be conducting meetings today to address supply chain issues.  Along those lines, a local news story says due to a worldwide aluminum shortage, there is a temporary interruption the production of Arizona license plates. The license plates are produced through Arizona Correctional Industries, a branch of the Arizona Department of Corrections, rehabilitation and
0 Comments
Swiss Franc jumps broadly in otherwise quiet markets today. Canadian Dollar is second strongest, then Dollar, but both are staying inside yesterday’s ranges. Sterling is currently the worst performing one, followed by New Zealand Dollar and then Yen. But the selling in the two are far from being clear. In other markets, Gold has a
0 Comments
GOLD LIVE MARKET PRICE – XAUUSD TIMEFRAMES M5-M15-M30-H1 TREND & POWER INDICATORS LIVE GOLD SPOT XAUUSD Market Forecast Trend & Power Indicators Timeframes M5-M15-M30-H1 Usage colors — The red Color bearish trend The green Color bullish trend Yellow horizontal lines – Expected support or resistance levels INDICATORS COMBINATION LIFETIME LICENSE FEE $200 ORDER BY EMAIL
0 Comments
NEW DELHI: Crude oil prices on Monday fell by Rs 25 to Rs 5,046 per barrel after the participants cut their positions. On the Multi Commodity Exchange, crude oil for the June delivery dropped by Rs 25, or 0.49 per cent, to Rs 5,046 per barrel with a business volume of 9,860 lots. Analysts said
0 Comments
A lackluster balance sheet, excessive debt load and over-leveraged exposure to Bitcoin have crashed MicroStrategy stock by more than 63% since February already. Nevertheless, the business intelligence company has ignored the risks of its frothy valuations, and it now wants to raise more debt and buy Bitcoin with proceeds (BTC). MicroStrategy announced on June 7 that
0 Comments
The stock has been halted and awaits being reopened The FDA has approved Biogen’s Alzheimer drug Aducanumab using an accelerated approval pathway.  The FDA does require Biogen to conduct a postapproval clinical trial and said that they can take away the approval upon unfavorable results.  
0 Comments